Perbedaan Bank Maspion Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Bank Maspion Indonesia Tbk. diperdagangkan di Rp490 (kapitalisasi pasar 8,96 T, volume 24 jam 76,1 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 187,4 rb). Perbedaan utamanya: Bank Maspion Indonesia Tbk. jauh lebih besar — sekitar 54,4× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (187,4 rb vs 76,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BMAS | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 8,96 T | 164,65 M |
Volume | 76,1 rb | 187,4 rb |
Lot | 761 | 1,87 rb |
Perputaran | 37,5 jt | 44,35 jt |
Harga Rata-rata | 492,76 | 236,67 |
Nilai Transaksi | 37,5 jt | 44,35 jt |
Harga Ekuilibrium Indikatif | 490 | 242 |
Volume Ekuilibrium Indikatif | 99 | 500 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Bank Maspion Indonesia Tbk (the Bank) was established on November 6, 1989 based on Notarial Deed No. 68 of Soetjipto, S.H., which was amended by Notarial Deed No. 49 dated December 5, 1989 of the same notary. The Bank started its commercial operations in 1990. As of December 31, 2012, the Bank has 10 domestic branches, 27 sub-branches, 10 cash offices and 45 Automatic Teller Machines (ATMs) located at Surabaya, Jakarta, Semarang, Denpasar, Medan, Bandung, Makassar, Malang, Solo and Purwokerto.
Selengkapnya di halaman BMAS →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →